Featured CME/CE Courses

• Webcast

  Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis

  CREDITS: Up to 1.0 AMA PRA Category 1 Credit™ ; Up to 1.0 ANCC Contact Hours per module
• Webcast

  Swollen Toe, Tip of the Iceberg–Assessing and Managing Hyperuricemia and Gout

  CREDITS: 0.50 AMA PRA Category 1 Credit™
• Webcast Series

  Focusing on Patients With Severe Asthma: From Guideline Recommendations to Daily Clinical Decision-Making

  CREDITS: 0.25 AMA PRA Category 1 Credit™ per module
• Webcast

  Focus on Lysosomal Diseases: New Frontiers for Accelerating Diagnosis and Optimizing Treatment

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Webcast

  Combating Drug Resistant Gram-negative Infections: Giving Conventional Antibodies New Capabilities

  CREDITS: 1.0 AMA PRA Category 1 Credit™, 1.0 nursing contact hours, 1.0 ACPE Credits
• Resource Center

  Evolving SMA Treatment Landscape

  CREDITS: 0.50 AMA PRA Category 1 Credit™ and 0.50 Nursing Contact Hour
• Webcast

  Injecting New Ideas Into Managing Type 2 Diabetes: Evolving Roles of GLP-1 Receptor Agonists

  CREDITS: 0.25 AMA PRA Category 1 Credit™, 0.25 Nursing Contact Hour
• Conference Reporter

  Management of Patients with Relapsed/Refractory Multiple Myeloma: Elsevier CME Independent Conference Highlights from EBMT and EHA 2018

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Webcast

  The Role of Micronutrients, Vitamins, and Supplements in Transforming Patient Health

  CREDITS: 2.5 AMA PRA Category 1 Credit™, 2.5 nursing contact hours
• Webcast Series

  ADVANCING THE CARE OF SEVERE ASTHMA: Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

  CREDITS: 0.25 AMA PRA Category 1 Credit™ per module
• Conference Reporter

  ATS 2018: An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD)

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Webcast

  An Update on Emerging Therapies for Cystic Fibrosis and Their Implications for Clinical Outcomes: Independent CME Conference Highlights from the 2018 European Cystic Fibrosis Society (ECFS) Conference

  CREDITS: 1.5 AMA PRA Category 1 Credit™
• Webcast Series

  Best Practices in Intrathecal Therapy for Chronic Pain: Patient Selection, Treatment Initiation, and Ongoing Monitoring

  CREDITS: 0.25 AMA PRA Category 1 Credit™ per module; 0.25 AANP Contact Hours (coming soon)
• Conference Reporter

  AHS 2018: An Update on Scientific Advances and Clinical Strategies in Migraine

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Webcast

  Focus on Uterine Fibroids: Evolving Options to Optimize Care

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Current and Future Therapies for Cytomegalovirus (CMV) Infection

  CREDITS: 1.0 AMA PRA Category 1 Credit(s)™
• Live Meeting

  The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis

  CREDITS: 1.75 AMA PRA Category 1 Credit(s)™ and 1.75 Nursing Contact Hours
• Webcast Series

  Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

  CREDITS: Up to 1.00 AMA PRA Category 1 Credit(s)™
• Resource Center

  Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center

• Conference Reporter

  AAIC 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN ALZHEIMER’S DISEASE FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE®

  CREDITS: 0.75 AMA PRA Category 1 Credit(s)™
• Webcast

  Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How, Why? A Roundtable Discussion

  CREDITS: 1.50 AMA PRA Category 1 Credit(s)™
• Medical Meeting Reporter

  ESMO 2017: A Therapeutic Update on the Management of Patients with Metastatic Renal Cell Carcinoma

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Medical Meeting Reporter

  ESMO 2017: A Therapeutic Update on the Management of Patients with Gastric Cancer

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Medical Meeting Reporter

  ESMO 2017: A Therapeutic Update on the Management of Patients with Advanced Hepatocellular Carcinoma

  CREDITS: 1.0 AMA PRA Category 1 Credit™
• Conference Reporter

  CHEST 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN COPD

  CREDITS: 1.00 AMA PRA Category 1 Credit™
• Webcast

  HOW IMMUNE CHECKPOINT INHIBITORS ARE CHANGING THE TREATMENT LANDSCAPE FOR METASTATIC MELANOMA

  CREDITS: 1.00 AMA PRA Category 1 Credit™
• Webcast

  Incorporating Immuno-oncology Agents into Solid and Liquid Tumor Treatment Paradigms: Highlights from ASCO 2017 – Expert Discussion

  CREDITS: 0.5 AMA PRA Category 1 Credit™
• Conference Reporter

  AN UPDATE ON EMERGING S1P THERAPEUTICS FOR THE MANAGEMENT OF PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  APPLYING PCSK9 INHIBITORS TO OPTIMIZE OUTCOMES IN PATIENTS WITH DYSLIPIDEMIA

  CREDITS: 1.50 AMA PRA Category 1 Credit(s)™
• Conference Reporter

  AHA 2017: APPLYING PCSK9 INHIBITORS TO IMPROVE OUTCOMES AND THE OVERALL QUALITY OF LIFE FOR PATIENTS WITH DYSLIPIDEMIA

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™